Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection [version 1; peer review: 2 approved]
Trichomonas vaginalis is the most common, curable non-viral sexually transmitted infection (STI) worldwide. Despite this burden of disease, it is not currently a reportable disease in the United States. Recent advances in the epidemiology, diagnosis, and management of T. vaginalis infection are desc...
Saved in:
Published in | F1000 research Vol. 8; p. 1666 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
Faculty of 1000 Ltd
2019
F1000 Research Limited F1000 Research Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Trichomonas vaginalis is the most common, curable non-viral sexually transmitted infection (STI) worldwide. Despite this burden of disease, it is not currently a reportable disease in the United States. Recent advances in the epidemiology, diagnosis, and management of
T. vaginalis infection are described in this article. This includes updated global and U.S. prevalence data in women and men as well as recent epidemiological data in HIV-infected individuals and pregnant women. Advances in molecular diagnostics are also reviewed, as are data from recent clinical trials regarding the treatment of trichomonas in women. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Competing interests: Christina A. Muzny is a consultant for Lupin Pharmaceuticals, BioFire Diagnostics, and Cepheid. She has also received honoraria from Roche Diagnostics and Becton Dickinson. Olivia T. Van Gerwen declares that she has no competing interests. |
ISSN: | 2046-1402 2046-1402 |
DOI: | 10.12688/f1000research.19972.1 |